Tenapanor

Products

Inquiry

Cat. No.: IBDI-436521

Tenapanor (AZD1722) is a potent and orally active sodium/hydrogen exchanger isoform 3 (NHE3) inhibitor. Tenapanor reduces intestinal phosphate absorption predominantly through reduction of passive paracellular phosphate flux. Tenapanor has the potential for the research of hyperphosphatemia.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	Na+/H+ Exchanger (NHE)
Molecular Weight	1145.05
Appearance	Solid
Synonyms	AZD1722, RDX5791
SMILES	O=C(NCCOCCOCCNS(=O)(C1=CC=CC([[email protected]@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)=C1)=O)NCCCCNC(NCCOCCOCCNS(=O)(C4=CC=CC([[email protected]@H]5CN(C)CC6=C5C=C(Cl)C=C6Cl)=C4)=O)=O
Purity	98.04%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.